Clinical Effectiveness and Cost-Effectiveness of the Use of the Thyroxine/Thyroxine-Binding Globulin Ratio to Detect Congenital Hypothyroidism of Thyroidal and Central Origin in a Neonatal Screening Program
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Context. Since the introduction of screening for congenital hypothyroidism (CH) in 1974, the optimal laboratory strategy has been the subject of debate. Objective. To assess the clinical effectiveness and cost-effectiveness of various types of thyroxine (T4)-based strategies to screen for CH. Design, Setting, and Participants. In the Netherlands, since January 1, 1995, a primary T4 determination with supplemental thyroid-stimulating hormone (TSH) and T4-binding globulin (TBG) measurements has been used. Results were calculated from cumulative findings for 1181079 children screened between January 1, 1995, and December 31, 2000. Main Outcome Measures. Rates of detection of patients with CH of thyroidal origin (CH-T) or CH of central origin (CH-C), false-positive rates, laboratory costs, and costs of initial diagnostic evaluations. Results. All known infants (n = 393) with CH-T and 92% (n = 66) of infants with CH-C were detected on the basis of low T4 levels, TSH elevation, and/or low T4/TBG ratios. If the decision to refer had been based solely on TSH elevation, then 94% of patients with CH-T and none of the patients with CH-C would have been detected. If low T4 levels (≤−3.0 SD) and TSH elevation had been used as the criteria for referral, then the rates of detection would have been 96% for CH-T and 31% for CH-C. The false-positive rates for the 3 approaches were 0.5, 3.3, and 4.7 cases per case detected, respectively. The introduction of the T4/TBG ratio into a program using a primary T4 with supplemental TSH approach generates an extra cost of $11206 per additional case detected. The average costs to detect 1 patient are comparable for the 3 approaches. In addition, our data revealed a substantially greater prevalence of CH-C than reported previously (1 case per 16404 children, compared with earlier estimates of 1 case per 26000 infants to 1 case per 29000 infants). Conclusions. The T4 plus TSH plus TBG approach is a recommendable strategy for neonatal CH screening. It offers outstanding detection of patients with CH-C, in addition to those with CH-T, with acceptable costs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TBG measurement prevents false-positive results due to TBG deficiency (5).”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [5]
In the citing paper
“Since 1995, the Dutch neonatal screening program has consisted of a 3-step approach, with T4 measurement as the first step in all neonates, TSH measurement in the lowest 20% of T4 concentrations, and thyroxine-binding globulin (TBG) measurement in the lowest 5%.”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [5]
In the citing paper
“This approach effectively detects primary and central CH.”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [5]
In the citing paper
“To date, central CH is the only pituitary hormone deficiency accessible for neonatal screening, which can be performed cost-effectively (5).”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [5]
In the citing paper
“The reported incidence of central CH detected through neonatal screening lies between 1 in 30,000 and 1 in 16,000, depending on the screening strategy (22–26).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485
Self-citationScreening for congenital hypothyroidism: Results of screening one million North American infants
Fisher, D. A., Dussault, J. H., Foley, T. P., Klein, A. H., LaFranchi, S., Larsen, P. R., Mitchell, M. L., Murphey, W. H., & Walfish, P. G. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80133-x · Cited by 372
What Do We Gain from the Sixth Stool Guaiac?
Neuhauser, D., & Lewicki, A. M. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507312930504 · Cited by 189
Oxford Handbook of Endocrinology and Diabetes
(2014) · doi:10.1093/med/9780199644438.001.0001 · Cited by 177
Kempers, M. J. E., van Tijn, D. A., van Trotsenburg, A. S. P., de Vijlder, J. J. M., Wiedijk, B. M., & Vulsma, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030665 · Cited by 160
Self-citationSecond International Conference on NeonatalThyroid Screening: Progress report
Fisher, D. A. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80228-5 · Cited by 125
Hanna, C. E., Krainz, P. L., Skeels, M. R., Miyahira, R. S., Sesser, D. E., & LAFRANCHI, S. H. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80276-1 · Cited by 104
The Anecdotal History of Screening for Congenital Hypothyroidism
Dussault, J. H. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4332 · Cited by 92
Léger, J., Larroque, B., Norton, J., & AFDPHE (2001) · Acta Paediatrica · doi:10.1080/080352501317130272 · Cited by 87
Cited by
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
Screening for congenital hypothyroidism: A worldwide view of strategies
Ford, G., & LaFranchi, S. H. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.008 · Cited by 274
Loeber, J. G., Platis, D., Zetterström, R. H., Almashanu, S., Boemer, F., Bonham, J. R., Borde, P., Brincat, I., Cheillan, D., Dekkers, E., et al. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7010015 · Cited by 243
“The Netherlands has also been screening for central hypothyroidism since the 1990s via the primary measurement of total thyroxine, supplemented by thyrotropin and thyroxine-binding globulin for samples, with 20% and 5% lowest total thyroxine levels, respectively [29,30].”
BackgroundSelf-citationLéger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358198 · Cited by 208
Metadata
- Authors
- Lanting, C. I., van Tijn, D. A., Loeber, J. G., Vulsma, T., de Vijlder, J. J. M., & Verkerk, P. H.
- Affiliations
- Netherlands Organisation for Applied Scientific Research (NL)
- Department of Pediatric Endocrinology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Netherlands
- National Institute for Public Health and the Environment (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2005-07-01
- Volume
- 116
- Issue
- 1
- Pages
- 168-173
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2109362965
- Cited by
- 97
- References
- 16
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 13 · 2020: 6 · 2019: 5 · 2018: 10 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 9 · 2013: 5 · 2012: 3
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- TNO Repository (submittedVersion)
- Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
- Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- congenital hypothyroidism, newborn screening, thyroxine-binding globulin, thyroxine, thyroid-stimulating hormone, central hypothyroidism, screening method, false positive rate, cost-effectiveness, prevalence, referral criteria
- MeSH terms
- Cost-Benefit Analysis, Costs and Cost Analysis, Congenital Hypothyroidism, False Positive Reactions, Humans, Infant, Newborn, Netherlands, Predictive Value of Tests, Sensitivity and Specificity, Thyrotropin, Thyroxine, Thyroxine-Binding Proteins, Neonatal Screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Effectiveness and Cost-Effectiveness of the Use of the Thyroxine/Thyroxine-Binding Globulin Ratio to Detect Congenital Hypothyroidism of Thyroidal and Central Origin in a Neonatal Screening Program. https://app.cochat.ai/papers/10.1542/peds.2004-2162
- The paper
- Lanting, C. I., van Tijn, D. A., Loeber, J. G., Vulsma, T., de Vijlder, J. J. M., & Verkerk, P. H. (2005). Clinical Effectiveness and Cost-Effectiveness of the Use of the Thyroxine/Thyroxine-Binding Globulin Ratio to Detect Congenital Hypothyroidism of Thyroidal and Central Origin in a Neonatal Screening Program. Pediatrics. https://doi.org/10.1542/peds.2004-2162
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.